Login / Signup

Does the 2017 revision improve the ability of GOLD to predict risk of future moderate and severe exacerbation?

Serhat ErolElif SenYagmur Gizem KilicAhmed YousifOznur Akkoca YildizTuran AcicanSevgi Saryal
Published in: The clinical respiratory journal (2018)
Low FEV1 was an important risk factor for future exacerbations. Downstaging of C1/D1 patients caused heterogeneity in A/B with including patients with low and high risk of future exacerbation. This resulted in a low discriminative power of GOLD 2017 regarding the risk of future exacerbation in groups A and B. This may cause underestimation of disease severity and inadequate treatment especially in A/B patients with low FEV1 .
Keyphrases